Compounds > carbamates

carbamates and tetrahydrofuran

carbamates has been researched along with tetrahydrofuran in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's0 (0.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cohen, J; de Lara, E; Dellaria, JF; Hutchins, CW; Kempf, DJ; Maki, RG; Rosenberg, SH; Spina, KP; Stein, HH; Woods, KW1
Bellahsene, T; Blavet, N; Dive, G; Favre, E; Godfroid, JJ; Le Texier, L; Pirotzky, E; Redeuilh, C1
Amano, M; Aoki, M; Chapsal, B; Das, D; Ghosh, AK; Ide, K; Koh, Y; Leschenko, S; Mitsuya, H; Yedidi, RS1
Agniswamy, J; Ghosh, AK; Louis, JM; Rao, KV; Sayer, JM; Shen, CH; Wang, YF; Weber, IT; Xu, CX1
Agniswamy, J; Ghosh, AK; Louis, JM; Shen, CH; Weber, IT; Yashchuk, S1

Other Studies

5 other study(ies) available for carbamates and tetrahydrofuran

ArticleYear
Potent, low molecular weight renin inhibitors containing a C-terminal heterocycle: hydrogen bonding at the active site.
    Journal of medicinal chemistry, 1990, Volume: 33, Issue:6

    Topics: Carbamates; Chemical Phenomena; Chemistry; Furans; Heterocyclic Compounds; Hydrogen Bonding; Lactones; Molecular Conformation; Renin; Structure-Activity Relationship

1990
Structure-activity relationships in platelet-activating factor (PAF). 7. Tetrahydrofuran derivatives as dual PAF antagonists and acetylcholinesterase inhibitors. Synthesis and PAF-antagonistic activity.
    Journal of lipid mediators and cell signalling, 1996, Volume: 13, Issue:3

    Topics: Carbamates; Cholinesterase Inhibitors; Esters; Furans; Isomerism; Platelet Activating Factor; Structure-Activity Relationship

1996
Novel HIV-1 protease inhibitors (PIs) containing a bicyclic P2 functional moiety, tetrahydropyrano-tetrahydrofuran, that are potent against multi-PI-resistant HIV-1 variants.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:4

    Topics: Animals; Carbamates; Cell Line; Chlorocebus aethiops; COS Cells; Drug Resistance, Viral; Furans; HIV Protease Inhibitors; HIV-1; Humans; Pyrans; Sulfonamides

2011
Extreme multidrug resistant HIV-1 protease with 20 mutations is resistant to novel protease inhibitors with P1'-pyrrolidinone or P2-tris-tetrahydrofuran.
    Journal of medicinal chemistry, 2013, May-23, Volume: 56, Issue:10

    Topics: Binding Sites; Calorimetry, Differential Scanning; Carbamates; Crystallization; Darunavir; Drug Resistance, Multiple; Drug Resistance, Viral; Escherichia coli; Furans; Genes, Synthetic; HIV Protease; HIV Protease Inhibitors; HIV-1; Humans; Models, Molecular; Mutation; Pyrrolidinones; Structure-Activity Relationship; Sulfonamides

2013
Substituted Bis-THF Protease Inhibitors with Improved Potency against Highly Resistant Mature HIV-1 Protease PR20.
    Journal of medicinal chemistry, 2015, Jun-25, Volume: 58, Issue:12

    Topics: Carbamates; Crystallography, X-Ray; Darunavir; Drug Resistance, Viral; Furans; HIV Infections; HIV Protease; HIV Protease Inhibitors; HIV-1; Humans; Models, Molecular; Mutation; Structure-Activity Relationship; Sulfonamides

2015